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The authors of the above mentioned paper would like to make the following amendment to the author affiliations.

Kazumi Tagawa's affiliation currently reads "Department of Surgery, Shioda Hospital, Katsuura City, Japan". The affiliation should read "Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan".

Finally, the authors would like to make the following amendments to Fig. [2](#Fig2){ref-type="fig"}. The x-axis labels for both Fig. [2](#Fig2){ref-type="fig"}a and Fig. [2](#Fig2){ref-type="fig"}b currently read \"Time from TACE refractory (years)\". The labels should read \"Time (years)\". The corrected Fig. [2](#Fig2){ref-type="fig"} is provided here.Fig. 2Cumulative survival rates for **a** SOR vs. CON and **b** mSOR vs. mCON. *CON* transcatheter arterial chemoembolization, *mCON* matched transcatheter arterial chemoembolization, *mSOR* matched sorafenib, *SOR* sorafenib

The online version of the original article can be found under doi:10.1007/s12325-017-0524-9.
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